FAVERIO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 7.925
EU - Europa 4.072
AS - Asia 2.065
SA - Sud America 140
AF - Africa 18
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.233
Nazione #
US - Stati Uniti d'America 7.828
IT - Italia 1.176
SG - Singapore 811
DE - Germania 793
SE - Svezia 563
CN - Cina 549
IE - Irlanda 479
RU - Federazione Russa 391
HK - Hong Kong 282
ID - Indonesia 166
GB - Regno Unito 165
BR - Brasile 114
UA - Ucraina 91
AT - Austria 85
CA - Canada 80
FI - Finlandia 72
VN - Vietnam 67
IN - India 62
FR - Francia 57
NL - Olanda 46
DK - Danimarca 41
BE - Belgio 35
TR - Turchia 33
CZ - Repubblica Ceca 23
JP - Giappone 19
CH - Svizzera 12
ES - Italia 11
MX - Messico 11
PK - Pakistan 11
PH - Filippine 10
IR - Iran 9
AU - Australia 8
CL - Cile 7
CO - Colombia 7
MN - Mongolia 7
KR - Corea 6
PE - Perù 6
RO - Romania 6
BG - Bulgaria 4
GR - Grecia 4
IL - Israele 4
NZ - Nuova Zelanda 4
SC - Seychelles 4
AR - Argentina 3
BD - Bangladesh 3
EG - Egitto 3
IQ - Iraq 3
KZ - Kazakistan 3
MA - Marocco 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
EE - Estonia 2
LK - Sri Lanka 2
LT - Lituania 2
MM - Myanmar 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UG - Uganda 2
BH - Bahrain 1
BO - Bolivia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 14.233
Città #
Ann Arbor 2.176
Fairfield 687
Chandler 678
Singapore 665
Frankfurt am Main 587
Dublin 463
Wilmington 414
Ashburn 395
Houston 339
Milan 324
Woodbridge 307
Santa Clara 295
Hong Kong 282
Seattle 261
New York 235
Cambridge 203
Princeton 172
Jakarta 163
Dearborn 155
Shanghai 103
Altamura 85
Lawrence 80
Nanjing 79
Jacksonville 78
Vienna 68
Fremont 58
Helsinki 55
Beijing 54
Boardman 52
Chicago 47
Guangzhou 47
San Diego 46
London 43
Council Bluffs 42
Dong Ket 35
Rome 34
Brussels 33
Toronto 30
Monza 28
Nuremberg 25
Lissone 24
Andover 23
Jinan 23
Nanchang 23
Brno 20
Hangzhou 20
Los Angeles 17
Falls Church 15
Genoa 15
Jiaxing 14
Munich 14
Shenyang 14
Hebei 13
Ningbo 13
Ottawa 13
Tianjin 13
Pune 12
Turin 12
Bologna 10
Groningen 10
São Paulo 10
Zhengzhou 10
Zurich 10
Bari 9
Beauharnois 9
Edmonton 9
Kocaeli 9
Norwalk 9
Paris 9
Washington 9
Brescia 8
Carate Brianza 8
Changsha 8
Dallas 8
Palermo 8
Faisalabad 7
Hefei 7
Lachine 7
Lappeenranta 7
Leawood 7
Moscow 7
Naples 7
Sacramento 7
Amsterdam 6
Casorate Primo 6
Catania 6
Kunming 6
Madrid 6
Mariano Comense 6
Taizhou 6
Acquafredda 5
Ankara 5
Atlanta 5
Bogotá 5
Desio 5
Hanoi 5
Kiev 5
Manila 5
Marietta 5
Peschiera Borromeo 5
Totale 10.522
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 356
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 348
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 307
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 294
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 293
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 292
Early referral to palliative care services in patients with IPF: A tool to take a step forward 280
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 269
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 241
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 239
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 227
Janus-faced amiodarone-induced pneumopathy 206
Impact of traffic-related air pollution on pulmonary oxidative stress 204
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 200
A second update on mapping the human genetic architecture of COVID-19 199
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 194
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 192
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 192
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 190
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 185
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 182
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 179
A 61-year-old female with chronic cough and purulent sputum 177
Mapping the human genetic architecture of COVID-19 177
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 176
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 172
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians 171
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 166
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 164
Hospital admission decision for patients with community-acquired pneumonia 163
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 163
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 159
Clinical differences in sarcoidosis patients with and without lymphoma: A single-centre retrospective cohort analysis 156
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 156
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 155
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 154
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 153
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 150
The management of community-acquired pneumonia in the elderly 148
Long-term prognosis in community-acquired pneumonia 145
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 144
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 143
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study 141
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 141
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 140
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 139
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 138
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 137
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 137
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 135
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 135
Long-term macrolides in diffuse interstitial lung diseases 134
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 134
History of lung volume reduction procedures 127
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 125
Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan 125
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 123
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 122
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients 121
Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update 121
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 120
Individualizing duration of antibiotic therapy in community-acquired pneumonia 116
Non-antibiotic therapies for CAP 116
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 115
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 110
New biomarkers in community-acquired pneumonia: Another step in improving outcome prediction 107
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 106
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 105
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements 105
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 105
Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function 103
European Respiratory Society International Congress 2017: highlights from the Clinical Assembly 101
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 99
Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders 99
A multidisciplinary approach to screen the post-COVID-19 conditions 98
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 97
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 97
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 93
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 91
COVID-19. The Pulmonologist and the new scenarios on a new pandemic 91
Utility and safety of bronchoscopy during the SARS-CoV-2 outbreak in Italy: A retrospective, multicentre study 90
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 87
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia 84
How to choose the duration of antibiotic therapy in patients with pneumonia 82
Early outcomes in CAP: Clinical stability, clinical failure and nonresolving pneumonia 81
Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions 78
Differences of Acute Exacerbations in Idiopathic Pulmonary Fibrosis compared to otherfibrotic lung diseases 76
Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association 74
Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia 73
RA-ILD: does more detailed radiological classification add something to our knowledge of this condition? 69
Re: Selective digestive decontamination saves lives whilst preventing resistance 69
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 66
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management 64
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 63
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 62
Interstitial lung disease in ANCA-associated vasculitis: another step forward 60
Diagnostic delay in bronchiectasis: an Italian perspective 57
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 57
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population 52
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 52
Totale 14.306
Categoria #
all - tutte 59.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020764 0 0 0 0 0 0 0 184 176 192 111 101
2020/20212.900 120 131 270 268 311 309 298 358 229 226 172 208
2021/20221.818 192 193 230 174 100 159 75 122 74 98 134 267
2022/20232.658 278 694 307 232 191 386 44 185 170 27 82 62
2023/20241.960 54 74 123 100 239 452 339 96 121 52 39 271
2024/20252.674 300 557 293 261 431 334 375 123 0 0 0 0
Totale 14.858